Fund detail
HHLR Advisors / Hillhouse (Zhang Lei)
china, growth, hillhouse, active
Quarters
30
2021-06-30
$9.71B
Positions
89
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4D MOLECULAR THERAPEUTICS IN | $0 | 0 | -157,500 | -100.00% | 0.07% | ||||||
| 2 | ARCUS BIOSCIENCES INC | $0 | 0 | -50,000 | -100.00% | 0.01% | ||||||
| 3 | CALLIDITAS THERAPEUTICS AB | $0 | 0 | -944,716 | -100.00% | 0.26% | ||||||
| 4 | CHINA BIOLOGIC PRODS HLDGS I | $0 | 0 | -2,962,076 | -100.00% | 3.47% | ||||||
| 5 | CYTOKINETICS INC | $0 | 0 | -230,718 | -100.00% | 0.05% | ||||||
| 6 | GENMAB A/S | $0 | 0 | -265,529 | -100.00% | 0.09% | ||||||
| 7 | GRUBHUB INC | $0 | 0 | -169,386 | -100.00% | 0.10% | ||||||
| 8 | MERUS N V | $0 | 0 | -46,532 | -100.00% | 0.01% | ||||||
| 9 | NEXTCURE INC | $0 | 0 | -563,907 | -100.00% | 0.06% | ||||||
| 10 | PAYPAL HLDGS INC | $0 | 0 | -40,000 | -100.00% | 0.10% | ||||||
| 11 | TCR2 THERAPEUTICS INC | $0 | 0 | -39,577 | -100.00% | 0.01% |